Clinical TrialID 7184
N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
NCT01031927
Obsessive Compulsive Disorder
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7184
- Evidence Id
- 7184
- Core Evidence Id
- 7184
- Source Clinical Trial Id
- 7173
- Herb2 Clinical Trial Id
- HBCT007173
- Nct Id
- NCT01031927
- Title
- N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Obsessive Compulsive Disorder
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: N-methyl glycine
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 30
- Outcome Measure
- Yale-Brown Obsessive Compulsive Scale, week0, 2, 4, 6, 8, and 10
- Sponsor Collaborator
- China Medical University Hospital|Taipei City Hospital
- Funded By
- OTHER
- Location
- China Medical University Hospital, Taichung, Taiwan
- Other Id
- DMR96-IRB-75
- Start Date
- 2007-06
- Primary Completion Date
- 2009-02
- Completion Date
- First Posted
- 2009-12-15
- Results First Posted
- Last Update Posted
- 2009-12-29
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01031927
- Title Cn
- Title En
- N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
- Bilingual Status
- semi_complete